Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic review and meta-analysis

被引：0
作者：
Xiaoying Sun
Raheleh Roudi
Ting Dai
Shangya Chen
Bin Fan
Hongjin Li
Yaqiong Zhou
Min Zhou
Bo Zhu
Chengqian Yin
Bin Li
Xin Li
机构：
[1] Shanghai University of Traditional Chinese Medicine,Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
[2] Shanghai Academy of Traditional Chinese Medicine,Institute of Dermatology
[3] Iran University of Medical Sciences,Oncopathology Research Center
[4] Shandong Academy of Occupational Health and Occupational Medicine,Department of Toxicology
[5] Shandong Academy of Medical Science,Department of Pharmacology & Experimental Therapeutics
[6] Boston University School of Medicine,Department of Dermatology
[7] Shaanxi Traditional Chinese Medicine Hospital,undefined
来源：
BMC Cancer | / 19卷
关键词：
Non-small cell lung cancer; Oncology; Programmed cell death protein-1; Programmed cell death ligand 1; Inhibitor; Immune-related adverse event; Meta-analysis; Systematic review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[21]   A meta-analysis reveals prognostic role of programmed death ligand-1 in Asian patients with non-small cell lung cancer [J].
Hu, Xiao-yan ;
Zhang, Wei ;
Hu, Yue ;
Zhang, Yong ;
Gong, Rui ;
Liang, Jin-yan ;
Liu, Li .
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2016, 36 (03) :313-320
[22]   The prognostic role of programmed cell death-ligand 1 expression in non-small cell lung cancer patients: An updated meta-analysis [J].
Ma, Guangzhi ;
Deng, Yunfu ;
Jiang, Hai ;
Li, Wen ;
Wu, Qiang ;
Zhou, Qinghua .
CLINICA CHIMICA ACTA, 2018, 482 :101-107
[23]   Is neoadjuvant immunotherapy necessary in patients with programmed death ligand 1 expression-negative resectable non-small cell lung cancer? A systematic review and meta-analysis [J].
Zhang, Shu-Ling ;
Tian, Yuan ;
Yu, Jing ;
Zhang, Jie-Hui ;
Sun, Li ;
Huang, Le-Tian ;
Ma, Jie-Tao ;
Han, Cheng-Bo .
LUNG CANCER, 2024, 191
[24]   Prognostic value of soluble programmed cell death ligand-1 in patients with non-small-cell lung cancer: a meta-analysis [J].
Wang, Yan ;
He, Haiyun .
IMMUNOTHERAPY, 2022, :945-956
[25]   Use of programmed cell death protein ligand 1 assay to predict the outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors [J].
Carmelo Tibaldi ;
Alice Lunghi ;
Editta Baldini .
World Journal of Clinical Oncology, 2017, (04) :320-328
[26]   Correlation between immune-related adverse events and the efficacy of PD-1/PD-L1 inhibitors in the treatment of non-small cell lung cancer: systematic review and meta-analysis [J].
Zhang, Qian ;
Wang, Wei ;
Yuan, Qi ;
Li, Li ;
Wang, Yu-Chao ;
Chi, Chuan-Zhen ;
Xu, Chun-Hua .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 89 (01) :1-9
[27]   Correlation between immune-related adverse events and the efficacy of PD-1/PD-L1 inhibitors in the treatment of non-small cell lung cancer: systematic review and meta-analysis [J].
Qian Zhang ;
Wei Wang ;
Qi Yuan ;
Li Li ;
Yu-Chao Wang ;
Chuan-Zhen Chi ;
Chun-Hua Xu .
Cancer Chemotherapy and Pharmacology, 2022, 89 :1-9
[28]   The prediction potential of neutrophil-to-lymphocyte ratio for the therapeutic outcomes of programmed death receptor-1/programmed death ligand 1 inhibitors in non-small cell lung cancer patients A meta-analysis [J].
Huang, Ying ;
Shen, Aizong .
MEDICINE, 2020, 99 (34) :E21718
[29]   Current and future drug combination strategies based on programmed death-1/programmed death-ligand 1 inhibitors in non-small cell lung cancer [J].
Cheng Ying ;
Li Hui ;
Zhang Liang ;
Liu JingJing ;
Yang ChangLiang ;
Zhang Shuang .
中华医学杂志英文版, 2021, 134 (15) :1780-1788
[30]   Current and future drug combination strategies based on programmed death-1/programmed death-ligand 1 inhibitors in non-small cell lung cancer [J].
Cheng, Ying ;
Li, Hui ;
Zhang, Liang ;
Liu, Jing-Jing ;
Yang, Chang-Liang ;
Zhang, Shuang .
CHINESE MEDICAL JOURNAL, 2021, 134 (15) :1780-1788
12345